Drug comparisons
Semaglutide vs Sotagliflozin
Compare Semaglutide (Ozempic) vs Sotagliflozin (Inpefa): GLP-1 vs dual SGLT inhibitor for T2D, weight loss, and heart failure. See which may be better.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients who also have heart failure or high cardiovascular risk, weighing a GLP-1 agonist against a dual SGLT inhibitor.
Bottom line
Semaglutide is generally stronger for weight reduction and A1C lowering, while Sotagliflozin offers distinct cardiorenal protection, so the better option is highly patient-specific.
All medication comparisons